Brevan Howard Capital Management’s Merck MRK Stock Holding History

Brevan Howard Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.62M	Sell	55,029 -69,117	-56%	-$7.98M	0.06%	178
2025 Q4	$13.1M	Buy	124,146 +31,029	+33%	+$2.91M	0.14%	91
2025 Q3	$7.82M	Sell	93,117 -355,802	-79%	-$29.3M	0.03%	147
2025 Q2	$35.5M	Buy	+448,919	New	+$35.7M	0.21%	47
2025 Q1	–	Sell	-82,648	Closed	-$8.22M	–	1344
2024 Q4	$8.22M	Buy	82,648 +71,381	+634%	+$7.36M	0.05%	83
2024 Q3	$1.28M	Buy	+11,267	New	+$1.34M	0.01%	380
2024 Q2	–	Sell	-98,883	Closed	-$13M	–	1278
2024 Q1	$13M	Buy	98,883 +68,734	+228%	+$8.47M	0.12%	40
2023 Q4	$3.29M	Buy	+30,149	New	+$3.13M	0.04%	68

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brevan Howard Capital Management's MRK Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Merck (MRK) stake by 56% in Q1 2026, selling an estimated $7.98M and leaving 55,029 shares worth $6.62M. The position accounts for 0.06% of the portfolio, ranked #178.

Brevan Howard Capital Management first reported a position in MRK in Q4 2023 and has held it in 8 quarters since. The position peaked at $35.5M in Q2 2025. 3,781 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Brevan Howard Capital Management held 55,029 shares of Merck worth $6.62M as of Q1 2026.
Brevan Howard Capital Management sold 69,117 Merck shares in Q1 2026, an estimated $7.98M.
Merck made up 0.06% of Brevan Howard Capital Management's portfolio in Q1 2026, its #178 holding.
Brevan Howard Capital Management first reported a position in Merck in Q4 2023 and has held it in 8 quarters since.
Brevan Howard Capital Management's Merck position peaked at $35.5M in Q2 2025.
3,781 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.